Evaluation of thrombocytopenia in systemic lupus erythematosus patients in a tertiary care hospital: clinical implications and prognostic significance
DOI:
https://doi.org/10.18203/2320-6012.ijrms20250959Keywords:
Autoimmune disorders, Thrombocytopenia, Systemic lupus erythematosus, Prognosis, Disease severity, Hematological complicationsAbstract
Background: Thrombocytopenia is a common hematological complication in systemic lupus erythematosus (SLE), associated with increased disease severity and adverse outcomes. This study aimed to evaluate the clinical implications and prognostic significance of thrombocytopenia in SLE patients at a tertiary care hospital in Bangladesh.
Methods: A cross-sectional study was conducted at the Sir Salimullah Medical College Mitford Hospital with 42 SLE patients. Data were collected on demographic characteristics, medical history, risk factors, clinical assessments, laboratory findings, and treatment outcomes. Statistical analyses were performed to identify associations between thrombocytopenia, disease severity, and outcomes.
Results: The study population was predominantly female (73.81%) and aged 25-34 years (52.38%). Thrombocytopenia was present with a mean platelet count of 54,523±648.97/μl, and symptoms included easy bruising (35.71%) and petechiae (45.24%). Severe disease activity was observed in 80.95% of patients, with frequent hospitalizations and poor prognostic outcomes significantly associated with thrombocytopenia (p<0.05). Shorter disease duration correlated with more severe symptoms (r=0.52, p=0.018), and fewer disease flares were linked to better prognoses (r=0.49, p=0.015). Standard therapies yielded limited improvement, with 30.95% showing improvement, 33.33% experiencing no change, and 35.71% worsening.
Conclusions: Thrombocytopenia is a significant marker of disease burden and poor outcomes in SLE patients. Comprehensive monitoring and personalized management strategies are essential to address its clinical and prognostic implications, particularly in resource-constrained settings.
Metrics
References
Ahmmad AM, Yeasmin S, Islam MN, Akter MS, Islam MS. Pattern of initial clinical presentation of systemic lupus erythematosus: a hospital-based cross-sectional study from Bangladesh. Mymensingh Med J. 2022;31(3):812-8.
Fernández M, Alarcón GS, Apte M, Andrade RM, Vilá LM, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort: XLIII. The significance of thrombocytopenia as a prognostic factor. Arth Rheum. 2007;56(2):614-21. DOI: https://doi.org/10.1002/art.22376
Rahman SA, Islam MI, Talukder MK, Islam MM, Huque SS, Roy RR. Presentation of childhood systemic lupus erythematosus in a tertiary care hospital. Bangladesh J Child Health. 2014;38(3):124-9. DOI: https://doi.org/10.3329/bjch.v38i3.22819
Chen Z, Zhong H, Dong G. Thrombocytopenia as a Prognostic Marker for systemic lupus erythematosus: a systematic review and meta-analysis. Am J Med Sci. 2019;357(6):461-7. DOI: https://doi.org/10.1016/j.amjms.2019.03.002
Baroni Pietto MC, Lev PR, Glembotsky AC, Marín Oyarzún CP, Gomez G, Collado V, et al. Pathogenic mechanisms contributing to thrombocytopenia in patients with systemic lupus erythematosus. Platelets. 2022;33(5):743-54. DOI: https://doi.org/10.1080/09537104.2021.1988547
Ziakas PD, Routsias JG, Giannouli S, Tasidou A, Tzioufas AG, Voulgarelis M. Suspects in the tale of lupus-associated thrombocytopenia. Clin Exp Immunol. 2006;145(1):71-80. DOI: https://doi.org/10.1111/j.1365-2249.2006.03122.x
Khan A, Shah MH, Nauman M, Hakim I, Shahid G, Niaz P, et al. Clinical manifestations of patients with systemic lupus erythematosus (SLE) in Khyber Pakhtunkhwa. J Pak Med Assoc. 2017;67(8):1180-5.
Sufian ABMA, Kashem MA, Biswas S. Pattern of hematological manifestations in patients with systemic lupus erythematosus attending in a tertiary care hospital. J Med. 2017;18(2):86-91. DOI: https://doi.org/10.3329/jom.v18i2.33686
Raza MA, Khan MIH. Systemic lupus erythematosus: disease manifestations in patients from central Punjab (Pakistan). Int J Clin Rheumatol. 2012;7(6):607. DOI: https://doi.org/10.2217/ijr.12.69
Zhao H, Li S, Yang R. Thrombocytopenia in patients with systemic lupus erythematosus: significant in the clinical implication and prognosis. Platelets. 2010;21(5):380-5. DOI: https://doi.org/10.3109/09537101003735564
Crosslin KL, Wiginton KL. Sex differences in disease severity among patients with systemic lupus erythematosus. Gend Med. 2011;8(6):365-71. DOI: https://doi.org/10.1016/j.genm.2011.10.003
Pamuk ON, Balci MA, Donmez S, Tsokos GC. The incidence and prevalence of systemic lupus erythematosus in Thrace, 2003-2014: a 12-year epidemiological study. Lupus. 2016;25(1):102-9. DOI: https://doi.org/10.1177/0961203315603141
Ktona E, Barbullushi M, Backa T, Idrizi A, Shpata V, Roshi E. Evaluation of thrombocytopenia in systemic lupus erythematosus and correlation with different organs damages. Mater Sociomed. 2014;26(2):122-4. DOI: https://doi.org/10.5455/msm.2014.26.122-124
Assunção H, Rodrigues M, Prata AR, Luís M, da Silva JAP, Inês L. Predictors of hospitalization in patients with systemic lupus erythematosus: a 10-year cohort study. Clin Rheumatol. 2022;41(10):2977-86. DOI: https://doi.org/10.1007/s10067-022-06251-7
Kalunian KC, Kim M, Xie X, Baskaran A, Daly RP, Merrill JT. Impact of standard of care treatments and disease variables on outcomes in systemic lupus erythematosus trials: analysis from the Lupus Foundation of America Collective Data Analysis Initiative. Eur J Rheumatol. 2016;3(1):13-9. DOI: https://doi.org/10.5152/eurjrheum.2015.0048
Downloads
Published
How to Cite
Issue
Section
